The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Will Be The Estimated Market Valuation Of The COVID-19 Current Therapy Market By The End Of 2030?
The size of the covid-19 current therapy market has experienced a significant decline over recent years. Projections indicate a decrease from $2.35 billion in 2025 to $1.57 billion in 2026, at a compound annual growth rate (CAGR) of -33.2%. This historical reduction is attributable to several factors, including the abrupt emergence of covid-19, elevated hospitalization figures, the scarcity of initial treatment choices, a reduction in governmental and healthcare programs, and fewer emergency drug authorizations.
The market for current COVID-19 therapies is anticipated to experience a significant decrease over the coming years. By 2030, its value is projected to fall to $0.31 billion, with a compound annual growth rate (CAGR) of -33.2%. This projected reduction is primarily due to a decrease in telemedicine usage for COVID-19 management and limited growth in home care services. Key developments expected during this timeframe involve an increase in the uptake of antiviral and monoclonal antibody treatments, a greater application of corticosteroids for severe COVID-19 infections, an expansion in home care and remote patient monitoring for the virus, the growth of supplement and immune support interventions, and the incorporation of combination and experimental therapies into treatment plans.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3247&type=smp
Which Market Drivers Are Supporting The Expansion Of The COVID-19 Current Therapy Market?
The growth of the COVID-19 current therapy market is anticipated to be significantly propelled by the ongoing expansion of healthcare infrastructure. The healthcare industry encompasses various economic sectors dedicated to offering products and services for patient care, including curing, prevention, rehabilitation, and palliative measures. Robust healthcare infrastructure is essential for the effective deployment of COVID-19 therapies, facilitating prompt patient attention, supporting clinical trials and research, and ensuring critical resources for optimal treatment delivery. For instance, data from the American Health Care Association, a US-based nonprofit organization, showed an increase in the number of hospitals in the US to 6,129 in May 2023, up from 6,093 in 2022. Furthermore, a May 2023 report by the Office for National Statistics, a UK-based government department, indicated a substantial rise in UK healthcare spending, by 9.4% in nominal terms and 9.7% in real terms. Consequently, the continuous expansion within the healthcare industry is a key driver for the COVID-19 current therapy market’s growth.
Which Segment Classifications Shape The COVID-19 Current Therapy Market?
The covid-19 current therapy market covered in this report is segmented –
1) By Drug Type: Antiviral, Monoclonal Antibodies, Corticosteroid, Supplements, Antimalarial, Interferons And Interleukin Inhibitors, Other Anti-Infective Drugs
2) By Route Of Administration: Oral, Intravenous
3) By End-User: Hospitals, Clinics, Home Care, Others
Subsegments:
1) By Antiviral: Remdesivir, Oseltamivir, Favipiravir, Nirmatrelvir Or ritonavir (Paxlovid)
2) By Monoclonal Antibodies: Bamlanivimab, Casirivimab Or Imdevimab (REGEN-COV), Sotrovimab, Etesevimab
3) By Corticosteroid: Dexamethasone, Hydrocortisone, Prednisone
4) By Supplements: Vitamin D, Vitamin C, Zinc, Quercetin
5) By Antimalarial: Hydroxychloroquine, Chloroquine
6) By Interferons and Interleukin Inhibitors: Interferon beta-1a, Interleukin-6 inhibitors
7) By Other Anti-Infective Drugs: Antibiotics, Antifungal Agents
How Are Trends Impacting The COVID-19 Current Therapy Market?
Leading companies within the COVID-19 current therapy market are intensifying their efforts to introduce innovative offerings, such as COVID-19 oral antiviral treatments, to secure a competitive advantage. Antiviral treatment refers to the administration of medications crafted to impede the replication and spread of viruses inside the body. For instance, in April 2024, Invivyd, a US-based company dedicated to developing antibody-based therapies for serious viral infectious diseases, provided an update on the introduction of PEMGARDA™. This came after its emergency use authorization (EUA) from The U.S. Food and Drug Administration (FDA), leading to PEMGARDA’s swift commercial availability. The treatment is intended for the prevention of COVID-19 in individuals with moderate-to-severe immune compromise.
Which Companies Are Expanding Their Footprint In The COVID-19 Current Therapy Market?
Major companies operating in the covid-19 current therapy market are Gilead Sciences Inc., Ipca Laboratories Limited, Zydus Cadila, Regeneron Pharmaceuticals Inc., Sun Pharmaceutical Industries Limited, AbbVie, Glenmark Pharmaceuticals Limited, Eli Lilly and Company, Wallace Pharmaceuticals Inc., Canary Health Technologies, Thermo Fisher Scientific
Read the full covid-19 current therapy market report here:
https://www.thebusinessresearchcompany.com/report/coronavirus-current-therapy-global-market-report
How Is The COVID-19 Current Therapy Market Distributed Across Key Geographic Regions?
North America is the largest region in the COVID-19 current therapy market in 2025. Middle East is expected to be the fastest-growing region in the global COVID-19 current therapy market share during the forecast period. The regions covered in the covid-19 current therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored COVID-19 Current Therapy Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=3247&type=smp
Browse Through More Reports Similar to the Global COVID-19 Current Therapy Market 2026, By The Business Research Company
Hydroxychloroquines Market Report 2026
https://www.thebusinessresearchcompany.com/report/hydroxychloroquines-global-market-report
Covid 19 Detection Test Kits And Consumables Market Report 2026
Covid 19 Rapid Test Kits Market 2026
https://www.thebusinessresearchcompany.com/report/covid-19-rapid-test-kits-market
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model